Glimepiride 0.5 mg and Metformin 500 mg
Price range: $55.00 through $200.00
| Quantity Value | Price | Quantity | Add To Cart |
|---|---|---|---|
| 100 Tablets | $55.00 |
|
|
| 200 Tablets | $100.00 |
|
|
| 300 Tablets | $135.00 |
|
|
| 500 Tablets | $200.00 |
|
SKU : N/A
Category : Weight Loss & Diabetic
Glimepiride 0.5 mg and Metformin 500 mg is a combination oral medication used as part of the management of type 2 diabetes mellitus. It contains glimepiride, which supports insulin release from the pancreas, and metformin, which helps support the body’s response to insulin.
Overview
Glimepiride 0.5 mg and Metformin 500 mg is a combination oral medication containing glimepiride and metformin. It is prescribed for use in adults as part of the management of type 2 diabetes mellitus under the supervision of a qualified healthcare professional.
This formulation includes two medicines with different mechanisms of action. The treatment plan, including dosage and duration, is determined by a healthcare provider based on individual clinical needs.
How It Works
Metformin reduces glucose production in the liver and supports the body’s response to insulin. It may also influence glucose absorption from the gastrointestinal tract.
Glimepiride belongs to the sulfonylurea class and works by stimulating insulin release from the pancreas. Together, these actions contribute to the regulation of blood glucose levels as part of an overall management approach.
Key Points
- Combination of glimepiride and metformin
- Oral tablet formulation
- Used under medical supervision
- Part of a broader diabetes management plan
Usage & Dosage
This medication should be taken as directed by a healthcare professional. It is typically taken with meals, depending on medical advice. Dosage may vary based on individual condition and response to treatment.
Patients should not adjust or discontinue the medication without consulting their healthcare provider. Regular monitoring may be recommended during use.
Safety Information
This medication should be used only under medical supervision. Patients should inform their healthcare provider about any existing medical conditions, including kidney or liver concerns, before starting treatment.
It is not indicated for use in type 1 diabetes or diabetic ketoacidosis.
Additional Information
For general information on diabetes management, visit:
👉
https://www.who.int/health-topics/diabetes
| Pack Size |
100 Tablets ,200 Tablets ,300 Tablets ,500 Tablets |
|---|
